EBRICTUS
EBRICTUS: Grup de Recerca Epidemiològica en Ictus des de l'Atenció Primària

Group leader
avatar_investigadors.jpg
Josep Lluis Clua Espuny
jlclua.ebre.ics@gencat.cat
avatar_grups_recerca.png

Publications

Madelung deformity

P. MOLTÓ-BALADO
ANALES DE PEDIATRIA. 2024 Apr 1; . doi:10.1016/j.anpedi.2024.02.004; PMID:38584013

Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation

P. MOLTÓ-BALADO, S. REVERTÉ-VILLARROYA, V. ALONSO-BARBERÁN, C. MONCLÚS-ARASA, M. BALADO-ALBIOL, J. CLUA-QUERALT and J. CLUA-ESPUNY
Technologies. 2024 Feb 1; . doi:10.3390/technologies12020013;

The Predictive Potential of C-Peptide in Differentiating Type 1 Diabetes From Type 2 Diabetes in an Outpatient Population in Abu Dhabi

S. IQBAL, A. ABU JAYYAB, A. ALRASHDI, S. SHUJAUDDIN, J. CLUA-ESPUNY and S. REVERTÉ-VILLARROYA
CLINICAL THERAPEUTICS. 2024 Sep 1; . doi:10.1016/j.clinthera.2024.07.002; PMID:39117487

Sex Disparities in the Direct Cost and Management of Stroke: A Population-Based Retrospective Study

J. LUCAS-NOLL, J. CLUA-ESPUNY, M. CARLES-LAVILA, C. SOLÀ-ADELL, I. ROCA-BURGUEÑO, A. PANISELLO-TAFALLA, E. GAVALDÀ-ESPELTA, L. QUERALT-TOMAS and M. LLEIXÀ-FORTUÑO
Healthcare. 2024 Jul 1; . doi:10.3390/healthcare12141369; PMID:39057512

Poor nutrition status as a predictor of major adverse cardiovascular events (MACE) in patients with atrial fibrillation

P. MOLTÓ-BALADO, J. CLUA-ESPUNY, S. REVERTÉ-VILLARROYA, M. BALADO-ALBIOL, M. GARCÍA-OLCINA, A. SIMEÓ-MONZÓ, A. SERRA-GARCIA and J. CANELA-ROYO
MEDICINA DE FAMILIA-SEMERGEN. 2025 Sep 1; . doi:10.1016/j.semerg.2025.102458; PMID:39922045